CRISPR-Complete: An In Vitro Engine for Optimizing CRISPR-Cas Performance
Abstract- Clustered regularly interspaced short palindromic repeat (CRISPR)-Cas systems have been widely applied to basic research questions and biotechnology, enabling the launch of a new class of powerful therapeutics: cell and gene therapies.
Optimizing Ribonucleoprotein (RNP) Complexes and Improving Multiplex Gene Editing Efficiency with Data-Driven gRNA Selection
In recent years, CRISPR-Cas gene editing has revolutionized the field of genetic engineering, creating unprecedented opportunities
Accelerating CRISPR-Cas Optimization with Quantitative DNA Binding Analysis
The incorporation of CRISPR-Cas gene editing techniques into genomic studies, sustainability research, and therapeutic development
In vitro CRISPR-Cas Cleavage Assays Streamline Gene Editing Workflows
CRISPR-Cas gene editing has revolutionized biological research and genetic engineering, enabling the launch of a new class
The CRISPR Analytics Platform™ Data for Optimized Gene Editing
Having trouble achieving consistent high-quality CRISPR edits? Here at CRISPR QC™, we’re familiar with the headache that comes with troubleshooting
CRISPR quality control on a chip
Combining the precision of CRISPR’s DNA searching ability with the speed and scalability of electronics, we have developed an electronic DNA search engine
CRISPR-Chip™ Displayed at German DHMD Museum
We are thrilled to share that our CRISPR-Chip™, the backbone of our CRISPR Analytics Platform™, is now being showcased at the German DHMD museum in Dresden as part of the esteemed exhibition ‘Of Genes and Human Beings.’ Seeing our innovative technology displayed alongside Watson and Crick’s DNA model is truly an honor and a testament […]
CRISPR Goes Global
CRISPR technology has revolutionized the field of gene editing, opening up new possibilities for scientific research, medical treatments, and agriculture. In this blog post, we will take a closer look at how CRISPR technology is being used across every continent on the globe. We will explore the innovative applications of CRISPR in each region and […]
CRISPR QC™ Announces Formation of Scientific Advisory Board
Read Original Article Here CRISPR QC™ announced the formation of its Scientific Advisory Board with the appointment of three distinguished members, Dr. Rodolphe Barrangou, Dr. Gene Dantsker, and Dr. Jared Carlson-Stevermer. Dr. Kiana Aran will be leading the advisory board. “I am excited to join the Scientific Advisory Board of CRISPR QC™ and contribute to […]
CRISPR QC™ Co-founder Kiana Aran Makes Inc.’s 2023 Female Founders List
Read Full Article Here CRISPR QC™ is proud to announce that co-founder Kiana Aran has been recognized by Inc. magazine as a top 200 Female Founder. This prestigious list highlights women entrepreneurs who are making a significant impact in their respective industries and driving change. “As a female founder, I hope to inspire other women […]
